Navigation Links
Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016
Date:6/25/2012

FARMINGTON, Conn., June 25, 2012 /PRNewswire-iReach/ -- The enzyme inhibitors industry in emerging markets has significant potential, in contrast to mature markets where growth is significantly slower. Having accurate market data and analysis is essential to companies that wish to compete on the global stage. With premium market research from the world's leading publishers, Global Information Inc. helps businesses stay on the cutting edge with the best forecasts, research, and analyses.

(Photo: http://photos.prnewswire.com/prnh/20120625/CG29914)

Global Information is pleased to announce the immediate availability of three significant new reports on Enzyme Inhibitors.

Global Markets for Enzyme Inhibitors -- Focus on Europe

Global Markets for Enzyme Inhibitors -- Focus on US

Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets

The overall goal of this series is to provide a comprehensive understanding of the current and future characteristics for enzyme inhibitors, which include proton pump inhibitors (PPIs), protease inhibitors, reverse transcriptase inhibitors, kinase inhibitors, statins, aromatase inhibitors, phosphodiesterase type 5 (PDE5) inhibitors, neuraminidase inhibitors, and angiotensin-converting enzyme (ACE) inhibitors.

Each report offers Market sizes with 5-year forecasts from 2011 to 2016 for enzyme inhibitors in the pharmaceutical and biotechnology industry. These include market projections and market shares as well as a technology SWOT analysis.

Due to patent expiry, the US Enzyme Inhibitors market declined in 2011, down to $44.9 billion from $46.8 billion in 2010. The US market is expected to recover slowly to $47.4 billion by 2016, at a CAGR of 1.1%. The US kinase inhibitors market fell to $10.4 billion in 2011 from $10.8 billion in 2010. This market is expected to recover to $11.6 billion by 2016, a CAGR of 2.2%.

European Markets held mostly flat in 2011. The European market for enzyme inhibitors was $32 billion in 2010 and rose to $32.4 billion in 2011, and will rise at a CAGR of 3.6% to reach nearly $38.7 billion by 2016. European sales of kinase inhibitors were also mostly flat, at $9.2 billion in 2010 and $9.4 billion in 2011, but are forecast to reach $11.6 billion by 2016 at a CAGR of 4.4%.

The greatest potential by far lies in the emerging markets of India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.  Enzyme inhibitors in these markets are estimated at $25.6 billion in 2010 and $27.2 billion in 2011, expected to rise at a CAGR of 8.7% and reach nearly $41.3 billion through 2016. Kinase inhibitors in particular were $8.2 billion in 2010 and $9.3 billion in 2011, set to grow at a CAGR of 13% to reach nearly $17.1 billion by 2016.

An Executive Summary of this analysis and a free sample of each report is available from Global Information, Inc:

Emerging Markets
http://www.giiresearch.com/report/bc245534-global-markets-enzyme-inhibitors-focus-on-emerging.html

US Markets
http://www.giiresearch.com/report/bc245535-global-markets-enzyme-inhibitors-focus-on-us.html

European Markets
http://www.giiresearch.com/report/bc245533-global-markets-enzyme-inhibitors-focus-on-europe.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Increasing Incidence of Cardiovascular Diseases to Drive The Cardiovascular Devices Market in Emerging Countries
2. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
3. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
4. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
5. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
6. Post-Recession, the Global Market for Surgical Equipment Picks Up Speed, Particularly In China and Emerging Economies
7. MD+DI, MPMN, Qmed and CMDM Announce Emerging Trends in Medical Device
8. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
9. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
10. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
11. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... , ... October 08, 2019 , ... ... at Western Pennsylvania & Ohio Valley Oral & Maxillofacial Surgery. This cutting-edge practice ... All-on-4® full arch dental implants to predictable jaw surgery with 3D ...
(Date:10/8/2019)... ... 08, 2019 , ... A free, interactive event highlighting innovations and ideas helping ... event, featuring thought leaders, innovators and health experts, will display innovations that could help ... to 5:30 p.m. CT on October 19 at the Coppertank Event Center in Austin, ...
(Date:10/8/2019)... ... , ... Corteva Agriscience and MicroMGx today announced a collaboration ... products. , Under the agreement, MicroMGx will apply its metabologenomics platform to accelerate ... agriculture industry, Corteva will use those starting points to discover and develop naturally ...
Breaking Medicine Technology:
(Date:10/10/2019)... ... October 10, 2019 , ... Santa Rosa ... services for the healthcare industry, has completed the first phase of a comprehensive ... Commonwealth of The Bahamas towards a fully integrated health information management system (iHIMS). ...
(Date:10/10/2019)... ... October 10, 2019 , ... In ... 21 was excited to hear the significant results of an independent study presented ... of Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline Malate ...
(Date:10/8/2019)... ... October 08, 2019 , ... What unique insights can three former Surgeons General ... wellness in the nation? That question will be answered at ICAA 2019: Shaping the ... Expo. The event will take place October 10-12, 2019, at the Gaylord Palms Resort ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... majority interest in Advanced Fertility Care (AFC), an advanced reproductive services (RE) facility ... expand the availability of RE services to expectant families throughout Arizona and the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... services for the Department of Veterans Affairs Community Care Referrals and Authorizations program. ... of the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by ...
Breaking Medicine News(10 mins):